| Intrinsic Valuation of: CCEP | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 4 | Market Cap | $40B | |||||
| 2021 | - | - (-) | P/E Ratio | 23 | Total Asset | $31B | |||||
| 2022 | $2B | - (-) | Net Income | $1B | Total Debt | $9B | |||||
| 2023 | $2B | 39.4% (10.8%) | EBITDA | $3B | Total Liab | $22B | |||||
| 2024 | $2B | -14.4% (-19.0%) | Opr Margin | 0.12 | Debt/Equity | 1.05 | |||||
| 2025 | $2B | 6.4% (-4.7%) | PreTax Margin | 11.22 | BV/Share | -20 | |||||
| 5Y Average FCF | $2B | 10.5% (-4.3%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (10.5%) | ||||||||||
| 2026 | $2B | MBG Intrinsic Value | $35 | ||||||||
| 2027 | $3B | ||||||||||
| 2028 | $3B | ||||||||||
| 2029 | $3B | ||||||||||
| 2030 | $3B | ||||||||||
| 2031 | $4B | ||||||||||
| Terminal Value | $80B | Net Worth/Share | $20 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $66B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $2B | $128 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $9B | WACC | 7.3% | 110 | 120 | 132 | 146 | 164 | |||
| Equity Value | $58B | 7.4% | 109 | 119 | 130 | 144 | 161 | ||||
| Shares Outstanding | 454,744,992 | 7.4% | 108 | 117 | 128 | 142 | 159 | ||||
| 7.9% | 98 | 105 | 114 | 125 | 139 | ||||||
| DCF Intrinsic Value | $128 | 8.4% | 89 | 95 | 103 | 112 | 122 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||